-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 MEXBGeHE0pA9UfjaUvRgt0Rd8At2ktPDP5EUKya00TvvXUKktA8bWoYVw7sYUk2q
 smr9096LmSBX8ZsVwD1Mfw==

<SEC-DOCUMENT>0001136261-09-000210.txt : 20090706
<SEC-HEADER>0001136261-09-000210.hdr.sgml : 20090703
<ACCEPTANCE-DATETIME>20090706164959
ACCESSION NUMBER:		0001136261-09-000210
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20090630
ITEM INFORMATION:		Unregistered Sales of Equity Securities
FILED AS OF DATE:		20090706
DATE AS OF CHANGE:		20090706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cardo Medical, Inc.
		CENTRAL INDEX KEY:			0000925741
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				232753988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21419
		FILM NUMBER:		09931224

	BUSINESS ADDRESS:	
		STREET 1:		9701 WILSHIRE BLVD., SUITE 1100
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212
		BUSINESS PHONE:		(310) 274-2036

	MAIL ADDRESS:	
		STREET 1:		9701 WILSHIRE BLVD., SUITE 1100
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLICKNSETTLE COM INC
		DATE OF NAME CHANGE:	20000823

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NAM CORP
		DATE OF NAME CHANGE:	19960802
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>body8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>July 6, 2009 8K DOC</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<font FACE="Times New Roman" SIZE="2">

<DIV align=left>
<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">
</DIV>

<FONT SIZE="3"><B><p align="center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</P></font></B>


<HR align=center SIZE=2 width="25%">
<BR>
<FONT SIZE="4"><B><p align="center">FORM 8-K</P></font></B>
<HR align=center SIZE=2 width="25%">


<FONT SIZE="3"><B><p align="center">
                                       CURRENT REPORT<BR>
          Pursuant to Section 13 or 15(d) of the  Securities Exchange Act of 1934
</P></B>

<FONT SIZE="2">
<p align="center">
    Date of Report (Date of earliest event reported): <B>
                                                    June 30, 2009</B>

<FONT SIZE="2"><font color="000000">
<P ALIGN="CENTER"><IMG SRC="logo.jpg">
<FONT SIZE="4"><B><p align="center">
                                    Cardo Medical, Inc.
</B></font><BR>
<FONT SIZE="2">
            <i>(Exact name of registrant as specified in its charter)</i>
</font></P>



<P>&nbsp;
<TABLE COLS=3 WIDTH="100%" ALIGN="CENTER">
<TR>
<TD>
<FONT SIZE="3"><B>
<CENTER><u>Delaware</u></CENTER>
</font></B>
</TD>
<TD>
<FONT SIZE="3"><B>
<CENTER><u>0-21419</u></CENTER>
</font></B>
</TD>
<TD>
<FONT SIZE="3"><B>
<CENTER><u> 23-2753988 </u></CENTER>
</font></B>
</TD>
</TR>

<TR>
<TD>
<FONT SIZE="2">
<CENTER>&nbsp;<i>(State of other jurisdiction of incorporation)</i></CENTER>
</font>
</TD>


<TD>
<FONT SIZE="2">
<CENTER>&nbsp;<i>(Commission File Number)</i></CENTER>
</font>
</TD>

<TD>
<FONT SIZE="2">
<CENTER><i>(I.R.S. Employer Identification Number)</i></CENTER>
</font>
</TD>
</TR>
</TABLE>
<BR>



<FONT SIZE="3"><B><p align="center">
                            9701 Wilshire Blvd., Suite 1100
<BR><U>
                              Beverly Hills, California  &nbsp;&nbsp;  90212
</U></B></font><BR>

<FONT SIZE="2">
       <i> (Address of principal executive offices including zip code)</i>
</font></P>

<FONT SIZE="3"><B><U><p align="center">
                                (310) 274-2036
</U></font></B><BR>

<FONT SIZE="2">
               <i>  (Registrant's telephone number, including area code)</i>
</font></P>

<p align="center"><FONT SIZE="3"><B>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></font></u><BR>


<FONT SIZE="2">
          <i>(Former Name or Former Address, if Changed Since Last Report)</i>
</font></P>


<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Written
communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Soliciting material
pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

<P align="left" style="font-size: 10pt"><FONT face="Wingdings">&#111;</FONT>&nbsp;&nbsp;Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

<DIV align=left>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">
</DIV>
<P style="PAGE-BREAK-BEFORE: always" align=left>


<FONT FACE="Times New Roman" SIZE="2">
<B><P>Item 3.02. &nbsp;&nbsp; Unregistered Sales of Equity Securities.</P>
</B>

<FONT SIZE=2><P ALIGN="JUSTIFY">On June 30, 2009, Cardo Medical, Inc., (the &quot;Company&quot;) received commitments from 43 investors to
purchase 8,689,319 shares of common stock, par value $0.001 per share (&quot;Common Stock&quot;) at a purchase price of $0.35
per share for aggregate gross proceeds of $3,041,260.30.  These shares have a 24 month lock up provision.  The Company is relying
on the exemption provided by Section 4(2) of the Securities Act of 1933, as amended (the &quot;Securities Act&quot;) for the issuance
of shares of common stock in the Company, which exception the Company believes is available because the securities were not
offered pursuant to a general solicitation and the status of the investors as &quot;accredited investors&quot; as defined in Regulation D
of the Securities Act.  </P>



<BR>
<BR>
<BR>
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" ALIGN=left>

<B><p align="center">
                                   SIGNATURES
</P></B>
<P>     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

<P>Date: July 6, 2009

<P>
<TABLE border=0 cellPadding=0 cellSpacing=0 width="100%">
  <TR>
    <TD width="38%"></TD>
    <TD width="62%"></TD></TR>
  <TR vAlign=toP>
    <TD>&nbsp;</TD>
    <TD align=left><FONT SIZE="2">
                                    Cardo Medical, Inc.
</TD></TR></TABLE>


<P>
<TABLE border=0 cellPadding=0 cellSpacing=0 width="100%">
  <TR>
    <TD width="38%"></TD>
    <TD width="62%"></TD></TR>
  <TR vAlign=toP>
    <TD>&nbsp;</TD>
    <TD align=left><FONT SIZE="2">
 By: &nbsp;  /s/ Derrick Romine
</TD></TR></TABLE>


<TABLE border=0 cellPadding=0 cellSpacing=0 width="100%">
  <TR>
    <TD width="38%"></TD>
    <TD width="62%"></TD></TR>
  <TR vAlign=toP>
    <TD>&nbsp;</TD>
    <TD align=left>
      <HR align=left SIZE=1 WIDTH=65%>
    </TD></TR>
  <TR vAlign=toP>
    <TD>&nbsp;</TD>
    <TD align=left><FONT SIZE="2">
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;   Derrick Romine
</TD></TR>
  <TR vAlign=toP>
    <TD>&nbsp;</TD>
    <TD align=left><FONT SIZE="2"><I>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer
  </I></TD></TR></TABLE></P>


<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" ALIGN=left>








</body>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_VP!#`0H+"PX-#AP0$!P[
M*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SO_P``1"`!B`2$#`2(``A$!`Q$!_\0`'``!``,``P$!````````
M``````4&!P$"!`,(_\0`3!```0,#`00%!P8*"0,%`````0`"`P0%$08'$B$Q
M$T%187$B,H&1H;'!%!4S4G2R(S4V0E1B<I/1TA<T-V-S@I*SX18D\$.#HL+Q
M_\0`&0$!`0$!`0$```````````````$$`P(%_\0`'Q$!`0`"`@,``P``````
M``````$"$0,Q!"%!$A-1_]T`!``H_]H`#`,!``(1`Q$`/P#9D1$!$1`1$0$1
M$!$1`1$0$15O5>K8M/PB&)HEK)!EK">#1VE!8T#F\LA9M26O5NJ8Q455PDI:
M9_%H+BT$=S1U>*]AV<5;!O1WMXD[=TCXJIM?<KE06E[7<[72S17.M=5.+_P9
M+R[#<=_%3BBN47"Y0$1<(.41<("\<%YMM55&D@KH))QG,;7@N&.?!>PK+](_
MVA3_`+4_O*)MJ*(N$5RB(@(B("(B`B(@(B(."<`J!&J8&YZ6,LP<9'$*>=YI
M\%C=;72L,@WN&\?>NW%QS/;SEEII\-V?6-S134DI^JYY:?4O/57._P!*"19F
M3#^ZES[%EL-S<'`[[FN'(@JPVS6-SHR`Z?Y3%]27B?0>:]Y>/9T\SDE2\^T*
M6C?N5EK?3N_O,CX+M%M%IY>4,?\`K4Q;K[:-0Q_)Y61]*X<8)V@Y\.HKPW;9
MQI^Y,)@A?02]4E,[`SWM/!<+->J][_CANN&N&1!'_K7QGV@10#+H8_\`6J'J
M#0.J[$QTM%(;E3#CO0C$C1WM_AE?73.S*]WS<J[[42T-*[B(A]*\>'YOIX]R
MANK6S:<)YQ#34`F>3@-:XDE3WS_70T?RNOHXJ.+'_J/.\?`+I%;;%H^DW;?0
MQMF+>!/E/=WEQXJAZMO<\S7.EG+W'J')O@@U&R7-MXM45>UFXV4NPW/8XCX+
MWJK[-WF30MO>3DGI/]QRM"BNKW!C'/<<!HR5E5DA.K-;R5%0-Z$.,SFGB-T'
M#6^Y:9=-XVJLW?.Z!^/'=*S[9<6BZUK3YW0#'AO<?@K$K2@,``<`%RBY45PJ
MA=M5WAETGM]JL[YGP.W72.:2#U]2MZCKG?+791O5M2R)SN(:!ESO0$13Y]7:
MJM6)KE:VB$GB=P@>L*X6.]4U]MS:NFR..Z]AYL=V*KW77]CK:"HHS35$K96.
M:"6`#..!YKR;+IG_`"BO@+CN[C'8[\D*IOVL&L-2U.G(Z5]/!'+T[G`[Y/#&
M/XJ,O.O9H9(Z2U4PGJ"P.D=@N#21R`'-?+:E_5;=_B/]P4QHBT4]%I^GJNC:
M:BJ9TDDA'$YY#/@A[VD;+<)JFPPUUP`AD+"Z7(W0W!/4>2JE?M!K*JM-+8:'
MI^.`]S2XN[P!U+W;2+@^EL<5+&XM^528=CK:.)'KPO3H.T0T.GX:K<!J*H;[
MWXXXSP'AA%1<.M+W;9F?/UJ='`XX,C6%N[\"HC1DC9=?22,.\Q_3.:>T%:96
M4D%=2OIJF)LD4@PYK@LQT/"*;7!@!R(A*S/;C@GQ&HSSQ4T+YIGAD;!ESG'`
M`5'JM?5M=5FFL%N=/C\]S22>_`Y#Q7TVFW&2"WTM#&XM%0XNDQUAN,#UGV*9
MT;:8;;IZF<V,":H8))7XXDGB!Z`BJY)K/4MID:Z[6H=$X\]TM]1XA7&RWJCO
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M_<_W'*UJI[,3G9_;3_B?[CE;%'IU>T/:6GD1@K);?,[1NM'LJ`1"UQC<<<XW
M<G#V'T%:XH346EZ+4$`Z4='4,&(YFCB.X]H52I>&6.>%LL3VO8\9:YIR"%W6
M:LLFL].DQ6Z9TT&<@1N#F_Z3R]"^XN6T"8;@I',/;T31[RIHVOU7.*6CFJ",
MB*-SR/`968Z2MK-57ZJKKHXRB/$CF$\'$G@/`85UTY2WKYOJ8]0/$KIG>2-X
M$AI&".'!5/\`Z>U'I:ZR5%FC-1"_@,8.6YY.':JE7JIHZ"BM=08Z:"%C(7'R
M6`8&%1]EO]?KO\)OO7O;1:KU+B"Z%MOH3](Q@PYX[.M=]#:?N=EN=8ZLI^CB
MDC#6.W@<D%#Z^.U+^JV[]M_N"M&F?R9MWV=GN4+KZRW"\P43:"#I3$]Y?Y0&
M,@=O@I^Q4TM'8J*FG;NRQ0M:]N>1`3XOU5]I],]]KHZ@`EL4I:[NWA_PIG1=
M;'6:6H]QP+H6=$\=A'_&%*W&WT]TH):*J9OQ2C!'9V$=ZST:>U3I>KD=:'.G
M@>?S,$.\6GK0Z:3(]L<;GO<&M:,DGJ"R[14K:C7;YF>;)TSAX%2K*+6.I/\`
MM[D_Y#1.^DW0&EP[,#BN]ATO76G6CZEE*6T#=]L;]X'R2.")VZ;4:5YBH*H#
M+&E\;CV$X(]Q5HTM6QUVFZ&5C@2V(,<.QS>!'L7KNEMIKM024=6S>CD'I!ZB
M.]42.QZJTK4/^:'?*J9QSNC!!\6GK\$5HDDC(HW22.#6-&23R`67:3!NNO75
ML;3N!\DY/8#D#WA>^JBUMJ-GR2H@%'3NX/X;@([^))\%:]-:;IM/499&>DGD
MXRRD<^X=@0[3*Y1%%$1$!$1`1$0=7>:?!8E<?/E_:/O6VN\T^"Q*Y'#I2?K'
MWK5X_=<^3I$22"-A)*C**WUVK+U':[<W)<?*>?-8WK<>Y=*Z:HK:N.@HV&2:
M9P8QK>9)X`+=-#:-I=)6AL>`^NF`=4S=I^J.X+KS<FIISX\=I'3>G:+3-HBM
M]$P`,&7OQQD=UN*EERHV^7'YOH'/:<2/\EG\5A]VN_2"U/>&F1T#7?@XN?>Y
M5S3>K?FF[F"I>30SNP?[MWUE%WFO+G%@=S/%0;CO<U]##BGXZKAGG=^GZ`:Y
MKVAS2"",@CK7FN5MI;M02T-;")8)6X<T^\=ZI>SO4[IV_,E;)F2-N:=SN;FC
MFWT*_+#GC<,M5WEW-HG2]E.GK!!:C)TH@<_=?CF"]SA["I=$7A1?-\\,1Q)*
MQA/'#G`+Z++]H#9*O5T-+$3O?)V-`[R7%$MTTYKFO:'-(<#R(/-<JH;.+H:N
MRR44CLOI'X&>>Z[B/;E7!%=7/:QI<]P:!S).%UCGBD.(Y&/(ZFN!5/VCW)T5
MOI[9"3TE6_+@.>Z".'I)'J4/LZ#Z?4];2O=ES8'-/'AEKP%=)MI:+E%%$1$!
M<+E$'@NMXHK+3-J*YY9&YVZ"&YXK[6^X4]SHHZRE<70R9W21CD<?!5;:9^((
M/M`^Z5(Z'_)"B\'_`'BB;]IIU;2LJ&TSZF)LSN49>-X^A?94>XZ'KJW51N3*
MUC8'RB0DD[[,=05X')""Y1$41$0$1$$1=M36NRU+*>NF<R1[=X`,)X9PI8'(
M!'6LPVF_CZF^S#[Q6FQ_1M\`B.Z(B*ZN\T^"P;452((YN/')]ZWEWFGP6`3V
MV;4NJH+-"2!-,>D</S&`Y<?4M/!=2URY/D638[I8R22:HK8^>8Z0.'H<_P"`
M]*UU>>AHJ>W44-'2QB."!@8QHZ@%Z%PRR_*[=)-33A4+5US$U<]C7>1`-P>/
M7_YW*YW*K%%;YZ@\V-./'J627BJ<0<NRYQXGO7;@QW=O.=U$/42F65Q)ZU\D
MZ\HM[+V__]&#AJ9J&KAK(';LD+P]I':%NEFN<5XM5/7PGR9F`D?5/6/05A+Q
MEI5VV6WIT=7/997>0\&:$'J=^</5@^@K=Y&&YO\`C/Q9:NFG(N%RL+0+-[L>
MFVJTK>>[)$/4,K2%FC3T^UD]>[,?8Q6)76PO.GMH4]"_R8IGNC[L'RF?#UK3
M"LZVD4+J6XT=W@RUSO)<X=3F\6G_`,[%9ZV_M9HUUX80'24X+/VSP]_N0BK!
MW_4FTP$>53T;O1AG\7+YZ2/1;1*UG:9V_P#RS\%*[-;9T5OJ+G(,R5+]UI/U
M6GCZSGU*)M'X#:E.WEO5$P]8)51I,TT=/`^:5X9'&TN<X\@`J#/J74&IZY]-
MIV,P4\?.7@"1VDGEX#BI3:-6R4VG6P,<6_*90QV/JCC\`H336L[38;-'2&DG
M=+DNE<T##G'T]F%(M<U53K73.[65E1\JI@1O\0]OIX9"NUBO,%]MC*V`;N?)
M>P\V.',*KUVT.SUM#/2R4=06RQEI!`ZQXKR;+JAXGKZ;)W-UK\=_)!8-6:NC
MT_&V"%C9JR09:TG@P=I59IAK^YQBMBGE8QWE-#BQ@([FKRT<8U#M'?\`*O+B
M$[SNGENLS@>P+5`,#"=)VR?4=_N-7:FVF\TQBK8)@_?+<;[<$9/5U]7-7G0W
MY(47^;[Q4/M.I(G6REJ]T=,R7<#OU2"<>Q3&AOR1H?\`-]XH3M!774MVIM=L
MMD-5NTAFB:8^C:>!`SQQGK5[<X-:7.(``R2>I9A?/[3X_M$/N:K;KRNDHM+S
M=$[==.X19'8>?L!2KM"7G7=;65IMVG83(_.Z)@S>+OV1V=Y7G%'M#:SIOE$I
M//=Z6//JY*4V;VN&"S.N.X#/4/+=X]30<8]>5<T$9IZ6Y36:&2[-W:LYWAN[
MI`SPR.U56HGUU=ZF44D0H(6/+1R;G!QG)&3Z%?%7+OKFTVJ5T`+ZJ=O`LB'`
M'L)2%5>IN>L]+2QSW"4U%.YV"'$/:>[(&05?K/=8;S;(:Z#(;(.+3S:1S"H=
M_P!85%XLM12FRRQQ2`'I79\G!!SR4KLQ>XV2I83P;4<.[R0B;]H3:;^/J;[,
M/O%:;']&WP"S+:;^/J;[,/O%:;']&WP"+]=T1%%=7^8[P6?;,K-BIN5\E9Y4
MLI@A)^J#EQ])QZEH+AEI':%Y;3;X[7;8:.+S8V\3VD\2?7E>IEK&QYL]O6N4
M1>7I6-;UK:>WPP%P!E>2?`?_`*LLN%5&^8@/&`M"USI6^ZBKHGVZ:ECACCW0
M)7N!SGCR![E27[(=6O<7&NMPS_>O_E6OBSPPQ[<<Y;4/TL?UPG2Q_7"EOZ'M
M6?IUN_>O_E3^A[5GZ=;OWK_Y5U_?B\?KJ)Z6/ZX7:W706F^4=>Q^.AE#G8ZV
M]8]65*?T/:M_3K=^]?\`RKJ[8WJMW.MMW[U_\JEYL+-+,+/;<(WMDC:]IRUP
M!!'6%V49INDKJ#3U%1W)\;ZJ"(1O=&26G'`')[L*36!H%F=D_#[4*IXX[LTQ
M]60M,5-T_I2X6[551=*IT)BDZ0M#'$G+CD=2L2I765N^<M-54;6YDC;TK/%O
M'W96:NNLE7I>DL<9+I!5DAO:"!NCUN*V5S0YI!&01@A4BTZ"EH-2BNEEB?21
M2.?$P9WOU<\,</@A5NM=$RW6RGHV#A#&&^)Z_:L\^@VL=F:GWM_Y6FCDJ96Z
M3N,VMV7J)\`IQ-&\@N.]@`9X8[DA7UVD4CZC3[)V-)%/,'.QV$$?P7TT/);[
MAIR&,PPNGI_P<@<T9Y\#ZE9IX(JF!\$S`^.1I:YIY$*BU.A+I:ZTU6G:_<!_
M,>[=<.[/(CQ1/J[?-]%^B0_NPOI%34\!)AACC)YEK0,JDBEV@S#HW5,,0^L7
M-^`5HL%#7V^VB&Y5@JY]\N,@SR/5DJ*SRDE;I_:,]U3Y$?RAX)/4U^<'VA:J
M"",@@@]:KFJ=(0:A:)XY.@K&-PU^/)<.QR@:6U:\H(Q205+#$.#7.D#@!W9X
MJ]IT^^TZNA%!2T(<#,Z3I"WL:`1\5-Z&_)&B_P`_WBH*IT#65%KGEGJQ5769
MS?PDCCNL`/$#K5FTQ;:BT6&GH:HL,L6]DL.1Q)/Q1?JBWS^T^/[1#[FJV:^H
MWU>EIC&"XP/;+@=@Y^PJ/N6DKC5ZS;>(W0"G;+&_!<=[#0,\,=RN3V-DC<R1
MH<QPPX'D0E-*;LWND4MH?;7/`F@>7-:>MIX\/3E714&Y[/ZFFK/EE@K.A=G+
M8WNW2T]SAU>*Y;2;07MZ$U#&#EOE[<^L<4%GU562T.F:ZH@<6R-CPTCJR0,^
MU579M:J.>FJ;A-&R6=LNXW>&=T8!SZ<JTT-GG?ITVR\3BIDD:YLDC2>()R.)
MZPJE3Z7U3IVKD-FGCFAD/6X#/B#U^"06;6DT4&DZX/<&E[`QH[22."B-E_XG
MK/M'_P!0NLND[W>XI);[7M=(UCN@@B.&-=C@2I/1=AK;!15,%:Z(F20/;T;B
M>K'8A]53:;^/J;[,/O%:;']&WP"IVLM)7&_72&IHW0AC(0P](X@YR3V=ZN3!
MA@!Z@A'9$111$1`1$0$1$!$1`1$0$1$'_]+9D1$!$1`1$0$1$!$1`1$0$1$!
2$1`7"(@Y1$0$1$!$1`1$0?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
